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Abstract
Background: Cardiovascular inflammation is a key contributor to the development of atherosclerosis and the
prediction of cardiovascular events among healthy women. An emerging literature suggests biomarkers of
inflammation vary by geography of residence at the state-level, and are associated with individual-level
socioeconomic status. Associations between cardiovascular inflammation and state-level socioeconomic conditions
have not been evaluated. The study objective is to estimate whether there are independent associations between
state-level socioeconomic conditions and individual-level biomarkers of inflammation, in excess of individual-level
income and clinical covariates among healthy women.
Methods: The authors examined cross-sectional multilevel associations among state-level socioeconomic
conditions, individual-level income, and biomarkers of inflammation among women (n = 26,029) in the Women’s
Health Study, a nation-wide cohort of healthy women free of cardiovascular diseases at enrollment. High sensitivity
C-reactive protein (hsCRP), soluble intercellular adhesion molecule-1 (sICAM-1) and fibrinogen were measured
between 1993 and 1996. Biomarker levels were examined among women within quartiles of state-level
socioeconomic conditions and within categories of individual-level income.
Results: The authors found that favorable state-level socioeconomic conditions were correlated with lower hsCRP,
in excess of individual-level income (e.g. state-level real per capital gross domestic product fixed effect
standardized Βeta coefficient [Std B] -0.03, 95% CI -0.05, -0.004). Individual-level income was more closely associated
with sICAM-1 (Std B -0.04, 95% CI -0.06, -0.03) and fibrinogen (Std B -0.05, 95% CI -0.06, -0.03) than state-level
conditions.
Conclusions: We found associations between state-level socioeconomic conditions and hsCRP among healthy
women. Personal household income was more closely associated with sICAM-1 and fibrinogen than state-level
socioeconomic conditions. Additional research should examine these associations in other cohorts, and investigate
what more-advantaged states do differently than less-advantaged states that may influence levels of cardiovascular
inflammation among healthy women.
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Cardiovascular inflammation is a major contributor to
atherosclerosis-related cardiovascular disease [1,2]. Bio-
markers of cardiovascular inflammation, including acute
phase reactants such as high-sensitivity C-reactive pro-
tein (hsCRP) and fibrinogen, and markers of vascular
wall inflammation such as soluble intercellular adhesion
molecule-1 (sICAM-1), each predict the risk of future
cardiovascular events, including incident myocardial
infarction and stroke, particularly among women [3,4].
Processes of inflammation reflect dynamic interactions
among cardiovascular disease risk factors including cho-
lesterol levels and high blood pressure, metabolic condi-
tions including obesity, insulin resistance and diabetes,
and behavioral factors such as smoking and exercise
[1,5-7].
An emerging literature also suggests that processes of
inflammation are socially patterned in healthy women.
In the United States, biomarkers of cardiovascular
inflammation have been associated with the socioeco-
nomic status (SES) of individuals, and the SES of small
geographic areas, namely residential neighborhoods
[8,9]. However, the macro socioeconomic conditions of
larger geographic areas have yet to be explored in rela-
tion to inflammation among healthy women. The so-
called “macrosocial,” or macro socioeconomic determi-
nants of health are thought to represent the large-scale
distribution of resources and policies that impact popu-
lation health [10]. It is known that traditional cardiovas-
cular disease risk factors and outcomes, including
h y p e r t e n s i o n ,d i a b e t e sa n ds t r o k e ,s h o wv a r i a t i o na t
large regional and geographic scales in the United States
[11-14]. We have recently shown that there is state-level
geographic variation in inflammatory biomarkers among
healthy women that is not completely explained by clini-
cal and behavioral characteristics [15]. Despite the
recognition of patterns of risk in large geographic areas,
few data explore macro socioeconomic characteristics as
contributors to these outcomes. Recent data from the
REGARDS study show that women who reside in states
in the southeastern US - known as the “stroke belt"-
have high levels of inflammation, measured by hsCRP
[12]. However, in the REGARDS study, socioeconomic
status measured at the individual level did not fully
explain the effect of state residence on the risk of
inflammation among women [12].
Macro socioeconomic conditions measured at the
state-level have not been evaluated as correlates of car-
diovascular inflammation among women. Our study
investigated the association between state-level macro
socioeconomic conditions and individual-level biomar-
kers of inflammation among healthy women free of car-
diovascular diseases in the Women’s Health Study.
Specifically, we hypothesized that state-level socioeco-
nomic conditions, namely, state-level wealth and pros-
perity, labor productivity, economic growth, poverty and
income inequality would be associated with biomarkers
of inflammation, and that these associations would not
be completely explained by individual-level household
income and clinical conditions among healthy women.
Based on prior work by Diez-Roux et al, we additionally
hypothesized that variability in biomarker levels would
depend on both state-level socioeconomic conditions as
well as personal household income [16]. We assess the
relative contributions of individual-level and state-level
socioeconomic conditions in a multilevel analytic
framework.
Methods
Study population
The present study is a cross-sectional analysis conducted
with baseline data from the participants of the Women’s
Health Study (WHS). The WHS is a nation-wide rando-
mized-controlled trial of the efficacy of aspirin and vita-
min E in the prevention of cardiovascular disease and
cancer among women [17,18]. Methods for participant
recruitment have been described previously [19]. The
baseline WHS cohort consists of 39,876 healthy middle-
aged and elderly women aged 38 and older who were
without cardiovascular disease or cancer at study entry
between 1993 and 1996. At study entry, all participants
completed questionnaires to survey their baseline demo-
graphic, clinical, and lifestyle/behavioral characteristics.
Baseline blood samples were obtained from 28,296 parti-
cipants to quantify levels of traditional and novel cardio-
vascular risk factors [18,20]. The Partners Instituional
Review Board reviewed and approved this study.
Analytic sample
Our initial sample consisted of all 28,296 partcipants
with a baseline blood sample. Data were missing in
12.8% of the study cohort (n = 3,632). The largest
source of missing data was item non-response due to
missing survey data on the personal annual household
income of WHS participants (n = 1,504 accounting for
5.3% of the data). Missing data on income were corre-
lated with participant’s age, cholesterol levels, body mass
index and hsCRP, where those missing income data
tended to be older, have lower total cholesterol levels,
lower body mass index and lower hsCRP. Thus we
imputed missing data for income in multivarible models,
using procedures for multiple imputation [21] in SAS
®
version 9.2 (SAS Institute, Cary, NC) with the PROC MI
and PROC MIANALYZE procedures.
Non-imputed samples (n = 24,664) excluding the
3,632 participants with missing income data were used
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multivarible analysis consisted of 26,029 participants
with complete data after imputing missing data on
income.
Measures
Outcome measures: biomarkers of cardiovascular
inflammation
The study outcome measures were biomarkers of
inflammation as quantified by blood plasma levels of (1)
hsCRP (mg/L), (2) sICAM-1 (ng/ml) and (3) fibrinogen
(mg/dL), each assessed separately. Assays used to quan-
tify biomarker levels have been described [20].
Key predictor variables: state-level macro socioeconomic
conditions
The primary predictor variables were measures of state-
level socioeconomic conditions: (1) state-level wealth and
prosperity, (2) state-level labor productivity, (3) state-level
poverty, (4) state-level income inequality and (5) state-level
average annual economic growth. State-level wealth and
prosperity were assessed with two separate measures (a)
1990 state-level real per-capita gross domestic product
(GDP) from the Bureau of Economic Analysis, and (b) the
1990 US Census state-level median household income.
GDP at the state-level in 1990 was calculated by the
Bureau of Economic Analysis using the Office of Manage-
ment and Budget Standard Industrial Classification (SIC)
[22]. GDP data were computed from all industry activity
within that year, accounting for inflation ("real GDP”), and
scaled for state population ("per capita GDP”) to allow
comparison across states of different sizes [22,23]. Median
household income was taken from the 1990 US Decennial
Census, and represents money income received in the
1989 calendar year from related and non-related house-
hold members aged 15 years and over. The US Census
estimated median income at the state-level as calcuated
from wages and salary income, self-employment income,
interest income, dividends, rental and royalty income, and
money income from social security, public assistance and
welfare income [24].
State-level labor productivity describes the value of
workers’ output - i.e., what workers do - as a contribu-
tion to the wealth of the economy, [25,26] in contrast to
wealth gained through capital income [25,27]. State per
employee earnings has been suggested as a measure of
labor productivity as it captures both the value of goods
and services produced by workers, as well as the
resources that accrue back to the employed population
through wages and salaries [25,28,29]. Per employee
earnings were calculated by the Morrison Institute for
Public Policy using Bureau of Economic Analysis data
on earnings from wages and salaries, proprietors’
income, employer contributions to employee pensions
and insurance payments, as distributed across the
employed population of the region. We obtained state-
level data on per employee earnings from the PEW Cen-
ter on the States for this analysis [25,26,29].
Poverty at the state-level was obtained from the 1990
US Decennial Census long form survey, measured as the
percentage of the total state-population with an annual
household income under the 1989 federal poverty
threshold, accounting for household size and age of the
householder. State-level income inequality was measured
as the Gini index of inequality. State-level Gini coeffi-
cients were obtained from the 1990 Decennial Census
based on 1989 household income data from the Census
long form survey [30].
The average annual growth in state-level real per
capita GDP was used as the measure of economic growth
at the state-level. Average annual growth statistics were
calculated by the Bureau of Economic Analysis across
the decade for which inflammatory biomarker data were
collected in the study, between 1990 and 1996.
Individual-level covariates: cardiovascular risk fac-
tors and personal annual household income Indivi-
dual-level covariates thought to correlate with
inflammation included in the analysis were: age, race/
ethnicity (non-Hispanic White versus non-White race/
ethnicity), body mass index (normal weight versus over-
weight and obese body mass index), low-density lipopro-
tein cholesterol (LDL-C), high-density lipoprotein
cholesterol (HDL-C), systolic blood pressure category,
t h ep r e s e n c eo fd i a b e t e s( d e f i n e db yp a r t i c i p a n ts e l f -
report and measured blood hemoglobin A1C equal or
greater than 6.5%), frequency of exercise (recreational
physical activity performed rarely or never, less than
once per week, 1 to 3 times per week, four or more
times per week), average daily caloric intake, smoking
status (never smoked, prior smoker, current smoker),
and the personal annual household income of the parti-
cipant. Assays used to quantify the blood-derived mea-
sures were certified by the National Heart, Lung, and
Blood Institute/Centers for Disease Control and Preven-
tion Lipid Standardization Program [20].
Statistical analysis
Descriptive data
We present descriptive means, medians and percentages
of demographic, behavioral and clinical characteriscs of
WHS participants by state-level median household
income, as well as ranges of all the state-level socioeco-
nomic measures. We used Spearman rank correlation
coefficients calculated in SAS
® to assess correlations
among state-level socioeconomic measures.
Multilevel associations with personal income and state-level
socioeconomic conditions
We hypothesized that biomarkers levels would vary
depending on both state-level socioeconomic conditions
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[16]. Thus, we present figures describing the median
values of biomarkers of inflammation within quartiles of
state-level socioeconomic conditions, and across cate-
gories of personal household income. To test for a mul-
tilevel effect of state-level socioeconomic conditions on
inflammatory biomarker levels in excess of personal
household income, we used the PROC MIXED proce-
dure in SAS
® to estimate associations between biomar-
kers of inflammation and state-level measures, adjusted
for individual-level personal income and covariates.
Standardized beta coefficient fixed effect estimates with
9 5 %c o n f i d e n c ei n t e r v a l sa r er e p o r t e df r o mm u l t i l e v e l
models. Due to the known skew toward lower values,
hsCRP was log-transformed prior to statistical analysis.
Adjustment for covariates and handing of missing data in
multivariable models
In multivariable models, we used a propensity score pre-
dicting body mass index (normal weight versus over-
weight and obese status) to account for the causal
relationships between adiposity and several metabolic
and behavioral variables (exercise, caloric intake, HDL-
C, LDL-C, diabetes, systolic blood pressure) as they
relate to inflammation [31]. We report multivariable
analyses with imputed data for income. Sensitivity ana-
lyses in multivariable multilevel models showed that
effect estimates were not substantively different in mod-
els with and without missing data on income.
Results
Table 1 describes demographic, behavioral and clinical
characteristics of the WHS study cohort by quartiles of
state-level median household income. State-level distri-
bution of participants in the Women’s Health Study
have been detailed previously [15]. WHS participants
who lived in states in the highest quartile of state med-
ian income (e.g., California, Connecticut, Massachu-
setts) tended to be younger, had higher personal
incomes, less frequently smoked, more frequently exer-
cised, were less likely to be obese, were less likely to
have diabetes, and had a better HDL-C profile than
WHS participants living in states in the lowest quartile
of state median income (e.g., Mississippi, West Virgi-
nia, Arkansas). High-income states had a higher per-
centage of non-White WHS participants, chiefly Asian/
Pacific Islander groups (e.g., California, 10% non-
White WHS participants) than lower-income states (e.
g., West Virginia, 2% non-White WHS participants).
Caloric intake was slightly higher among WHS partici-
pants in the highest-income states than lower-income
states. The mean systolic blood pressure category was
not substantively different across quartiles of state-
level median household income. The median value of
each inflammatory biomarker decreased with
increasing quartiles of state-level median household
income (Table 1).
T a b l e2d e s c r i b e st h er a n g eo fs o c i o e c o n o m i cc o n d i -
tions at the state level. Spearman rank correlation coeffi-
cients show that the measures of wealth and prosperity
(real per-capita GDP, state median household income)
and labor productivity (per employee earnings) were
tightly correlated (Table 3). Wealthy and prosperous
states tended to have stable economies (low levels of
average economic growth) between 1990 and 1996.
Poorer states, measured by the prevalence of state-level
poverty, tended to have higher levels of average annual
economic growth during this period. State-level income
inequality was directly correlated with state-level pov-
erty, and inversely related to median household income
(Table 3).
Figure 1 shows the multilevel relationship between
hsCRP, personal household income, and state-level eco-
nomic conditions. Across almost all state-level indica-
tors, women with low personal household incomes (≤
$19,999 annually) who lived in states with the most
favorable economic conditions (wealthy and prosperous,
high productivity, low poverty, low inequality) had lower
levels of inflammation than similarly low-income
women (≤ $19,999 annually) who lived in states with
the least favorable economic conditions. For example,
the median hsCRP for the lowest-income women who
lived in states in the least wealthy GDP quartile was 3.6
mg/L (standard error 0.47), compared to 2.0 mg/L (stan-
dard error 0.54) for the lowest-income women who lived
in states in the most wealthy GDP quartile (Figure 1).
Additionally, for most state-level indicators, the dis-
parity in hsCRP levels between women with the highest
($100,000 and greater) and lowest (≤ $19,999) personal
incomes was smallest under the most favorable eco-
nomic conditions. In particular, state-level income
inequality appeared to influence the range of inflamma-
tory hsCRP values. The difference in hsCRP between
the highest-income women (median hsCRP 1.5, standard
error 0.19), and the lowest-income women (median
hsCRP 2.0, standard error 0.41) was 0.5 points among
women living in states with the lowest income inequal-
ity. The difference in hsCRP between women with the
highest and lowest personal income was 1.5 points
among women in states with the highest income
inequality (Figure 1).
The trend in biomarker values associated with average
annual economic growth was the reverse of that seen
with other indicators. Women in states with the highest
average annual growth tended to have the highest levels
of hsCRP, with high hsCRP levels among the lowest-
income women.
Figures 2 and 3 display patterns for sICAM and fibri-
nogen. The protective pattern of favorable state-level
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among low-income women was not as pronounced as
that seen for hsCRP.
Table 4 quantifies the association between personal
household income and biomarkers of inflammation, as
well as the association between each state-level charac-
teristic and biomarker of inflammation in excess of per-
sonal household income, all adjusted for women’s
demographic, behavioral and clinical characteristics. Per-
sonal household income was independently associated
with sICAM-1 and fibinogen, where higher levels of per-
sonal income were associated with lower levels of
sICAM-1 and fibrinogen, after adjustement for indivi-
dual-level covariates (Table 4). When adjusted for indi-
vidual-level covariates, personal household income had a
positive association with hsCRP, where higher personal
incomes were associated with higher hsCRP. After pro-
pensity score adjustment for metabolic variables, this
association crossed zero (Std B 0.01, 95% CI -0.005,
0.02).
Table 1 Selected Demographic, Lifestyle, and Clinical Characteristics of Women’s Health Study Participants: By
Quartiles of State-Level Median Household Income
Quartiles of State-Level Median Household Income
a,b
WHS Participants
c
N = 24,664
$20,136-
$24,807
$25,257-
$27,854
$28,706-
$31,183
$32,181-
$41,721
Demographic
Age, median (IQR), y 53 (49-59) 53 ± 0.1 53 ± 0.1 53 ± 0.1 52 ± 0.1
NH-White
d 23,419 (95) 95 95 97 93
Non-White 1,245 (5) 5537
Hispanic 216 (1) 1.0 1.3 0.4 1.0
Non-Hispanic Black 422 (2) 2.2 1.5 1.1 2.3
Asian/Pacific Islander 327 (1) 0.5 0.9 0.8 2.4
Other/unknown race/ethnicity 280 (1) 1.3 1.1 0.9 1.3
Lowest income (< $19,999) 1,207 (4.9) 6.6 5.6 5.1 3.5
2 ($20,000-29,999) 2,379 (9.7) 11.8 11.3 10.4 6.8
3 ($30,000-39,999) 3,426 (13.9) 15.8 16.0 14.9 10.5
4 ($40,000-49,999) 4,091 (16.6) 18.9 17.8 16.9 14.5
5 ($50,000-99,999) 10,303 (41.8) 36.8 39.3 41.5 45.8
Highest income ($100,000+) 3,258 (13.2) 10.1 10.0 11.1 18.9
Lifestyle
Current smoker 2,848 (12) 13 12 11 11
Exercise rarely/never 9,121 (37) 42 37 36 36
Median Daily Caloric intake, median (IQR), kCal 1675 (1350-2053) 1673 ± 10 1660 ± 6 1680 ± 6 1682 ± 6
Clinical Covariates
HDL-C, median (IQR), mg/dL 52 (43-62) 50 ± 0.3 51 ± 0.2 52 ± 0.2 53 ± 0.2
LDL-C, median (IQR), mg/dL 121 (100-144) 122 ± 0.7 121 ± 0.4 121 ± 0.4 121 ± 0.4
BMI, median (IQR), kg/m
2 24.9 (22.5-28.3) 25.1 ± 0.1 24.8 ± 0.1 25.1 ± 0.1 24.6 ± 0.1
Systolic blood pressure category, mean ± SD,
mmHg
124 ± 14 124 ± 14 123 ± 14 124 ± 14 123 ± 14
Percent with diabetes 737 (3) 4333
Clinical Outcome Variables
hsCRP, median (IQR), mg/L 2.0 (0.8-4.4) 2.4 ± 0.1 2.2 ± 0.1 2.0 ± 0.1 1.8 ± 0.1
sICAM, median (IQR), ng/ml 343 (301-394) 351 ± 2 343 ± 1 343 ± 1 338 ± 1
Fibrinogen, median (IQR), mg/dL 351 (307-403) 355 ± 2 351 ± 1 350 ± 1 349 ± 1
Abbreviations: BMI, Body Mass Index; IQR, inter-quartile range.
a Median household income measured from 1990 U.S. Decennial Census. State-level quartiles are based on ranges of the 50 United States plus the District of
Columbia.
b Values are median ± standard error or mean ± standard deviation when appropriate.
c Figures are No.(%) unless otherwise noted.
d “Non-White” includes Black, Asian/Pacific Islander, and American Indian/Native American/Alaska Native.
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all three biomarkers, where rising quartiles of inequality
were associated with rising levels of hsCRP, sICAM-1
and fibrinogen (Table 4).
Rising quartiles of state-level wealth and prosperity (real
per-capita GDP and median household income) were
independently associated with lower levels of hsCRP and
sICAM-1, in excess of personal household income and
individual-level covariates (Table 4). Rising quartiles of
state-level poverty were associated with an increase in
hsCRP and sICAM-1, independent of personal household
income. Labor productivity was associated with hsCRP,
but not sICAM-1 or fibrinogen. Quartiles of average
annual economic growth were independently associated
with fibrinogen, but not other biomarkers. The relation
between economic growth and fibrinogen levels appeared
non-linear; a quadratic term did not appear to fit the data
(Std B -0.01, 95% CI -0.03, 0.01).
Discussion
Our study found that state-level macro socioeconomic
conditions were associated with biomarkers of
Table 2 U.S. State-Level Socioeconomic Conditions: Wealth and Prosperity, Growth, Income Inequality, Poverty and
Labor Productivity Measures
U.S. State-Level Percentile Ranges
a
N=5 1
5
th 25
th 50
th 75
th 95
th
Wealth and Prosperity
Real Per-capita GDP 1990, $ 18,872 21,520 24,387 28,369 38,663
Median Household Income 1990, $ 21,147 25,257 28,706 32,181 40,927
Economic Growth
Average Annual Growth Real Per-capita GDP 1990-1996 0.17 1.08 2.11 2.94 3.66
Income Inequality
Gini Coefficient of Inequality 1990 0.394 0.412 0.428 0.446 0.475
Poverty
Percent in Poverty 1990 (State-population percentage) 7.6 10.3 12.4 15.7 20.6
Labor Productivity
Per employee earnings 1990, $
b 29,124 32,545 34,502 38,582 47,262
a State-level percentiles are based on ranges of the 50 United States plus the District of Columbia.
b Per employee earnings are not calculated for the District of Columbia.
Table 3 Spearman Correlation Coefficients Among State-Level Wealth and Prosperity, Growth, Income Inequality,
Poverty, and Labor Productivity
Wealth and Prosperity Economic Growth Income
Inequality
Poverty Labor
Productivity
Real per-
capita GDP
a
Median
Household
Income
a
Average Annual Growth Real
Per-Capita GDP 1990-1996
a
Gini
Coefficient
a
Percent in
Poverty
a
Per
Employee
Earnings
a,b
Wealth and Prosperity
Real per-capita GDP
a 1.00 0.823** -0.694** -0.124 -0.616** 0.832**
Median Household Income
a 0.823** 1.00 -0.573** -0.329* -0.824** 0.821**
Economic Growth
Average Annual Growth Real
Per-Capita GDP 1990-1996
a
-0.694** -0.573** 1.00 0.003 0.391** -0.591**
Income Inequality
Gini Coefficient
a -0.124 -0.329* 0.003 1.00 0.671** 0.088
Poverty
Percent in Poverty
a -0.616** -0.824** 0.391** 0.671** 1.00 -0.535**
Labor Productivity
Per Employee
Earnings
a,b
0.832** 0.821** -0.591** 0.088 -0.535** 1.00
**Indicates results are statistically significant at P < 0.01.
*Indicates results are statistically significant at P < 0.05.
a Spearman correlation coefficients among linear variables obtained via Proc Corr procedure in SAS
®.
b Per employee earnings are not calculated for the District of Columbia.
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Health Study. C-reactive protein appeared to be most
sensitive to variation in state-level socioeconomic con-
ditions. High levels of wealth, prosperity and labor
productivity, and low levels of state-level poverty and
income inequality were associated with lower levels of
hsCRP. Importantly, we found that the variation in
hsCRP associated with state-level socioeconomic
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Page 7 of 12conditions was clinically meaningful among low-
income women. High-risk hsCRP values (≥ 3.0 mg/L)
were seen among low-income women in the most
deprived states, across almost all state-level indicators.
State-level income inequality was correlated with all
three biomarkers. In particular, decreasing state-level
income inequality was associated with smaller variation
in hsCRP between low-income and high-income
women. Personal household income, however,
appeared to be more strongly correlated with sICAM-1
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Figure 2 Median sICAM-1 (ng/ml) levels among Women’s Health Study participants by state-level characteristics and individual-level
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income within quartiles of state characteristics. State-level socio-economic conditions are based on ranges of the 50 United States plus the
District of Columbia. Per employee earnings are not calculated for the District of Columbia.
Clark et al. BMC Public Health 2012, 12:211
http://www.biomedcentral.com/1471-2458/12/211
Page 8 of 12and fibrinogen than state-level socioeconomic
conditions.
Our study contributes to the public health literature
on cardiovascular disease prevention by exploring the
relation of macro-level socioeconomic conditions to risk
factors for cardiovascular disease in healthy women. We
find that both relative (inequality) and absolute (wealth
and prosperity, productivity, poverty) measures of socio-
economic conditions at the state-level are associated
with inflammation among women in excess of their
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Figure 3 Median fibrinogen (mg/dL) levels among Women’s Health Study participants by state-level characteristics and individual-
level household income. Figures display unadjusted inflammatory biomarker median values and associated standard errors by personal
household income within quartiles of state-level characteristics. State -level socioeconomic conditions are based on ranges of the 50 United
States plus the District of Columbia. Per employee earnings are not calculated for the District of Columbia.
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Page 9 of 12personal income. To our knowledge, our study is the
first to relate macro-level socioeconomic conditions to
biomarkers of inflammation among healthy women in a
multilevel context. Previous studies have documented an
association between state-level socioeconomic condi-
tions and other health outcomes, including modest asso-
ciations between state-level income inequality and both
mortality and self-rated health [32-36]. Our results are
consistent with findings by Diez-Roux et al. who
observed correlations between state-level income
inequality and the presence of other cardiovascular dis-
ease risk factors, including increased BMI, high blood
pressure, and sedentary behavior among women, where
the largest effect sizes were observed in women with
low-incomes [16].
T h eW H Si sac o h o r to fp r e d o m i n a n t l yw h i t ew o m e n
employed in health professions, who have a low preva-
lence of traditional cardiovascular risk factors. Prior data
from the WHS show that increased hsCRP, in particular,
predicts incident myocardial infarction and stroke in this
lower-risk population [4]. Our study generates the
hypothesis that there are state-level socioeconomic path-
ways that impact inflammation, particularly hsCRP,
among even healthy women in this demographic who
have low-levels of traditional cardiovascular risk factors.
Our study also raises the question of why macro-level
socioeconomic conditions should matter to the health of
healthy women. Previous studies of area-level contribu-
tors to inflammation addresst h i sq u e s t i o nw i t haf o c u s
on neighborhood environments, and suggest that con-
textual differences are due to neighborhood conditions
that promote psychosocial stress, influence social norms,
or fail to facilitate healthy behaviors due to a lack of
health-promoting resources [9,37,38]. In contrast, state-
level socioeconomic conditions could potentially relate
to health status among women through differences in
state-level public health outlays, state investments in
safety-net insurance that influence early health care
seeking behavior, or by influencing the ability for states
to contribute resources to local agencies that foster
health promotion efforts [39-41]. Understanding state-
level influences on these early biomarkers of athero-
sclerosis may be important to shape novel population-
level prevention efforts in healthy women. Additional
research is needed to generate theories on the impact of
macro socioecomonic contexts on cardiovascular disease
risk [39,42].
Important limitations of our study should be consid-
ered, including the cross-sectional design which pre-
cludes inferring any causal relationships between
Table 4 Fixed Effect Estimates of Personal Household Income and State-Level SES Measures on Log(hsCRP), ICAM, and
Fibrinogen
Multivariable models
a (Log)hsCRP sICAM-1 Fibrinogen
Effect 95% CI Effect 95% CI Effect 95% CI
No state-level covariates
Model I. Personal household income category of WHS
participant
b,d
0.01 -0.005, 0.02 -0.04 -0.06, -0.03** -0.05 -0.06, -0.03**
Wealth and Prosperity
Model II. State real per-capita GDP quartiles
b,c,d -0.03 -0.05, -0.004* -0.02 -0.03, -0.002* -0.001 -0.02, 0.02
Model III. State median household income quartiles
b,c,d -0.05 -0.07, -0.03** -0.02 -0.03, -0.004* -0.005 -0.02, 0.01
Economic Growth
Model IV. State annual growth real per-capita GDP
quartiles 1990-1996
b,c,d
0.01 -0.01, 0.04 0.01 -0.005, 0.03 -0.02 -0.04, -0.001*
Income Inequality
Model V. State Gini coefficient quartiles
b,c,d 0.04 0.01, 0.06** 0.02 0.001, 0.03* 0.03 0.02, 0.05**
Poverty
Model VI. State percent poverty quartiles
b,c,d 0.05 0.03, 0.07** 0.02 0.002, 0.03* 0.01 -0.003, 0.03
Labor Productivity
Model VII. State earnings per employee quartiles
b,c,d -0.02 -0.05, -0.001* -0.01 -0.02, 0.01 0.01 -0.01, 0.03
a All models adjust for age, race and ethnicity, obese and overweight status, smoking status, personal household income category, listed covariates and
propensity score predicting obese and overweight status vs. normal weight status as a function of exercise level, average daily caloric intake, HDL, LDL, diabetes
status and systolic blood pressure.
b Figures are standardized fixed effect estimates obtained via the Proc Mixed procedure in SAS
® version 9.2. Effects are standardized beta coefficients
representing the standard deviation change in (Log)hsCRP, sICAM-1, or fibrinogen associated with a 1 standard deviation increase in the listed predictor variable.
c Multi-level models II - VII include state-level data on the 50 United States plus the District of Columbia. State earnings per employee are not calculated for the
District of Columbia.
d Missing income values in all multivariable models are imputed using the multiple imputation procedures on the above criteria via Proc MI and Proc MIANALYZE
in SAS
® version 9.2.
**Indicates results are statistically significant at P < 0.01.
*Indicates results are statistically significant at P < 0.05.
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Page 10 of 12biomarkers of inflammation and state-level socioeco-
nomic conditions. Additionally, our study focuses speci-
fically on cardiovascular inflammation among a cohort
of middle-aged and older women with a low prevalence
of cardiovasular risk factors. A strength of this approach
is that we are able to identify correlates of inflammation
early in the course of atherosclerosis, where public
health prevention may be most successful in slowing the
progression of cardiovascular disease. The greatest lim-
itation of this approach is the limit on generalizability to
higher-risk cohorts, including cohorts with greater eth-
nic diversity and greater comorbidities. Our findings
should be replicated in additional cohorts to assess their
generalizability and robustness. A related limitation is
that the WHS cohort was observed during an economic
downturn in the 1990s. Additional work in other
cohorts would be needed to observe the effect of state-
level socioeconomic conditions in better national eco-
nomic times, and to ascertain whether our findings
represent a cohort-specific phenomenon. Last, we mea-
sure exposure to state conditions in mid to late adult-
hood, and cannot explore important relationships
between inflammation and socioeconomic conditions
experienced across the lifecourse, as has been observed
at the individual-level in other studies [43].
Conclusions
Our study advances knowledge of cardiovascular disease
risk factors among healthy women by demonstrating a
clinically meaningful change in cardiovascular inflamma-
tion associated with state-level socioeconomic condi-
tions, particularly for hsCRP. The next steps of this line
of investigation would include replicating our findings
in other cohorts, and exploring mediating or confound-
ing contextual influences that could explain these
results. At this writing, the current macro socioeco-
nomic environment presents multiple natural experi-
ments at the state-level that will lead to state-level
differences in resources devoted to health safety-nets
and socioeconomic resources. Thus, attention to
changes in cardiovascular risk factors associated with
evolving state-level socioeconomic conditions may yield
insights into the role of state-level policies in the pre-
vention of cardiovascular disease among women [10,44].
If our findings are replicated, additional research should
explore what more advantaged states do differently than
less-advantaged states, that may contribute to reducing
early biomarkers of atherosclerosis in their populations.
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